Treat‐to‐Target in Gout Management? Comment on the Article by FitzGerald et al
- 20 September 2020
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatology
- Vol. 73 (3) , 543-544
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- 2020 American College of Rheumatology Guideline for the Management of GoutArthritis & Rheumatology, 2020
- Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized TrialThe American Journal of Medicine, 2019
- Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trialThe Lancet, 2018
- Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysisSeminars in Arthritis and Rheumatism, 2018
- A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutAnnals of the Rheumatic Diseases, 2017
- A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical TrialThe Permanente Journal, 2016